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Abstract 55 
Background & Aims: Dietary interventions for weight loss are effective therapies for non-56 
alcoholic fatty liver disease (NAFLD). The Mediterranean diet might benefit these patients but it is 57 
not followed consistently in Northern European countries. We examined factors that determine 58 
Mediterranean diet adoption and maintenance in a northern European population. 59 
Methods: We used a mixed-methods approach to investigate the effects of a 12-week 60 
Mediterranean diet intervention and perceived barriers and facilitators. Nineteen adults with 61 
NAFLD were recruited from a tertiary hepatology center in England. Participants were taught 62 
behavioral strategies through the provision of shopping lists, meal planners, and recipes; no 63 
advice was given on calorie allowances or physical activities. We used the 14-point Mediterranean 64 
diet assessment tool to assess dietary intake, based on a small number of foods in servings/day or 65 
servings/week, at baseline and after 12 weeks; participants were assigned scores of low (less than 66 
5 points), moderate (6–9 points), or high (10–14 points). Semi-structured interviews were audio 67 
recorded, transcribed, and analyzed using the framework method. 68 
Results: Twelve weeks after the dietary advice, Mediterranean diet adoption significantly 69 
increased from moderate to high (mean increase of 2.2 points; from 7.6+2.5 at baseline to 9.8+2.8 70 
at 12 weeks) (P=.006). This increase was associated with a mean reduction in bodyweight of 2.4 71 
kg (from 99.2 kg±17.0 at baseline to 96.8 kg±17.5 at 12 weeks) (P=.001) and increased serum 72 
concentrations of high-density lipoprotein cholesterol in 72% of participants (from 1.10±0.8 at 73 
baseline to 1.20±1.30 vs. 1.00±0.5 at 12 weeks) (P=.009). Increased nutrition knowledge and 74 
skills, family support, Mediterranean diet promotion in media and clinical settings, and the 75 
nutritional care facilitated diet changes. Barriers to Mediterranean diet uptake included an 76 
obesogenic environment, life stressors, and demand for convenience. Poor understanding of the 77 
causes and significance of NAFLD adversely affected readiness to change dietary habits. 78 
Conclusion: In an analysis of patients with NAFLD the northern United Kingdom, we found a 12-79 
week Mediterranean diet intervention was acceptable and associated with significant reductions in 80 
bodyweight and increased serum levels of high-density lipoprotein. We identified barriers and 81 
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facilitators that could support appropriate treatment adaptations and guide personalized 82 
intervention approaches. 83 
 84 
KEY WORDS: MDPS; HDL; metabolic liver disease; scalable diet treatments 85 
  86 
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Introduction 87 
Non-alcoholic fatty liver disease (NAFLD) affects up to 1-in 3-people, driving the global epidemic in 88 
chronic liver disease and consequent healthcare resource utilization (1, 2). NAFLD is a spectrum 89 
that encompasses isolated hepatic fat accumulation (steatosis, NAFL); through fat plus 90 
inflammation and hepatocyte injury (non-alcoholic steatohepatitis, NASH); ultimately to 91 
fibrosis/cirrhosis and potentially hepatocellular carcinoma (3-5). NAFLD is strongly associated with 92 
obesity and Type 2 diabetes and is an independent risk factor for the development of 93 
cardiovascular disease (CVD) (3). 94 
 95 
Lifestyle interventions are the cornerstone of treatment in the absence of effective 96 
pharmacotherapy. The exclusion of processed food and fructose is effective and calorie 97 
restrictions to achieve 7-10% weight loss improve clinical biochemistry, histological steatohepatitis 98 
and fibrosis (6-8).  The Mediterranean diet has been shown to ameliorate steatosis and improve 99 
insulin sensitivity/glucose tolerance, independent of weight loss (8-10).   100 
 101 
The factors that determine Mediterranean diet adoption in a northern European patient population 102 
are largely unknown. There is scarce evidence on the barriers and facilitators that influence an 103 
individual’s decision to adopt, and ability to maintain, such a diet long-term. There is limited 104 
information on whether an individual’s understanding of their underlying liver disease contributes 105 
to the adoption of a diet intervention or their perceptions of nutritional care.  These data will be 106 
highly relevant to the development of scalable diet treatments.  107 
 108 
The aim of the current study was, firstly, to determine key barriers and facilitators to adoption and 109 
maintenance of a 12-week Mediterranean diet intervention; and, secondly, to identify which 110 
adaptations would optimize treatment delivery and so maximize dietary behavior change.   111 
 112 
 113 
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Materials and methods 114 
This mixed-methods study was informed by a multi-disciplinary team comprising dietitians, 115 
psychologists and medical staff.  The aim was to explore participant’s experiences of following a 116 
12-week Mediterranean diet intervention. Semi-structured interviews were conducted to identify 117 
barriers and facilitators to diet uptake and maintenance. Socio-demographic data and routinely 118 
measured clinical and lifestyle variables were collected with preliminary changes reported.   The 119 
information was then integrated into the discussion of the overall results.  120 
 121 
Recruitment 122 
Patients were recruited from a specialist NAFLD clinic at a tertiary hepatology center, The 123 
Newcastle upon Tyne Hospitals NHS Foundation Trust, which covers a broad geographical area in 124 
Northern United Kingdom. Eligibility criteria included capacity to provide informed written consent, 125 
and ability to write and converse in English without an interpreter. Inclusion criteria: 18-75 years 126 
old with NAFLD, weekly alcohol consumption<14/21 units in the last 24months, non-smoker. 127 
Exclusion criteria: liver cirrhosis or neoplasm, prescribed other diet therapies, food intolerances 128 
and/or allergies. The study protocol was approved by East Midlands–Nottingham 1 Research 129 
Ethics Committee (REC reference 15/EM/0049). Informed written consent was obtained.  130 
 131 
Patients were identified by clinicians during routine appointments and invited to participate. 132 
Overall, a purposive sample of 20 patients with diverse socio-demographics were recruited.  The 133 
target sample size was informed by the researchers prior experience and other qualitative studies 134 
where data saturation is typically achieved between 12 and 20 participants (11, 12). 135 
 136 
Mediterranean diet intervention 137 
Mediterranean diet intervention combined nutrition counselling and education delivered in a single-138 
session by a dietitian. The intervention was based on the Mediterranean diet pyramid, a flexible 139 
model of dietary restraint (13).  Behavioral strategies of goal setting, action-planning and self-140 
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monitoring were targeted through the provision of shopping lists, meal planners and recipes. No 141 
advice was given on calorie allowances or physical activities. There was no further nutritional care 142 
provided over the 12 weeks, which reflects the standard follow-up interval in routine practice. 143 
 144 
Quantitative data collection and analysis 145 
Socio-demographic characteristics included age, gender, ethnicity, weekly gross equalized 146 
household income and marital status. Although the study was not powered to detect change in 147 
outcomes, key clinical and lifestyle variables ((blood lipids, bodyweight, and body mass index 148 
(BMI)) were monitored and presented.  The 14-point Mediterranean diet assessment tool (MDPS) 149 
measured diet intake based on a small number of foods in servings/day or servings/week. The 150 
range of possible scores are 0-14; low, moderate or high consumption respectively (<5, 6-9 and 151 
>10points) (14). 152 
 153 
Descriptive and inferential analyses were performed in SPSS (version 22) alpha p<0.05. 154 
Continuous and categorical data summarized as ((mean, standard deviation (SD) and counts 155 
(percentage)). Paired t-tests were used to assess changes in clinical and lifestyle data between 156 
baseline and study end for continuous variables. Mann-Whitney U test was used to assess if 157 
clinical and lifestyle data differed by the semi-categorical diet adoption score (MDPS). 158 
 159 
Qualitative data collection and analysis  160 
Face-to-face semi-structured interviews were completed after 12 weeks by a nutrition worker 161 
trained in qualitative research methods, audio-recorded and transcribed verbatim (interview 162 
schedule, Supplementary Material Table 1). Design and reporting was informed by consolidated 163 
criteria for reporting qualitative research (15).   Reflexivity was fostered by involving multiple 164 
researchers and using a diary to record impressions of the data and analysis process.   165 
 166 
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The framework method was used for thematic analysis of the transcripts (16). Two researcher’s 167 
independently coded the same 40% of transcripts to develop a working analytical framework. 168 
These initial findings were discussed during meetings to resolve any discrepancies.  This process 169 
was replicated with an additional 20% of transcripts, producing further iterations of the framework. 170 
Coding involved reading and re-reading transcripts, and coding the content into themes and 171 
subthemes until no further codes emerged. 172 
 173 
A third researcher was consulted to refine the framework and ensure consensus was reached on 174 
themes and subthemes. This triangulation of expertise captured different perspectives and 175 
enhanced trustworthiness of the findings. The framework was then applied by indexing the 176 
remaining transcripts using the existing categories and codes, until data saturation occurred at 19 177 
transcripts. The summarized abstracted data was charted into a matrix for each final theme. Direct 178 
participants quotes are reported to support themes and thus maximize confirmability.  179 
 180 
Results  181 
One participant left the study following a major change in social circumstances, unrelated to 182 
participation so the final sample comprised 19 participants. Baseline characteristics are presented 183 
in Table 1. Median weekly gross equalized household income was £320.5 (£76.9 to £1249.9), 184 
approx. €364.7 (€87.5 to €1422.4).  All participants had clinically significant NAFLD: 16 had biopsy 185 
proven NASH with Kleiner fibrosis stages ranging between F1-3. The other 3 patients had clinical 186 
and radiological evidence of NAFLD with intermediate-range NAFLD fibrosis scores (>-1.445). 187 
 188 
After 12-weeks diet intervention, Mediterranean diet adoption significantly increased from 189 
moderate to high levels (mean increase of 2.2 points; 7.6+2.5 at baseline to 9.8+2.8 at 12 weeks) 190 
(p=.006) (Fig.1). In parallel, 79% of participants reduced bodyweight by mean 2.4kg (from 191 
99.2kg±17.0 at baseline to 96.8kg±17.5 at 12 weeks) (p=.001) (Fig.2). Participants with improved 192 
diet uptake (72%) had increased high-density lipoprotein (HDL) cholesterol (1.10±0.8 to 1.20±1.30 193 
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vs. 1.00±0.5) (p=.009). No association between diet adoption and socio-demographics were 194 
observed.   195 
 196 
Interview data are described with participants identified by gender and age only.  Figure 1 provides 197 
the analytical framework for themes, subthemes, barriers and facilitators. The links between 198 
quotes and the framework are presented (Supplementary Material Table 2).   199 
 200 
NAFLD conceptualization  201 
Poor understanding about NAFLD appeared to influence the priority placed on following dietary 202 
advice. NAFLD was not well-defined and knowledge of the potential to induce disease 203 
regression/reduce progression was limited. Illness-related demands were perceived as lethargy, 204 
discomfort, pain, bloating, anxiety, disordered temperature regulation and altered immunity. 205 
Conversely, several reported no symptoms, or attributed symptoms to diabetes or ageing. 206 
 207 
NAFLD causality and the strength of these associations produced responses that incorporated 208 
physiological drivers, lifestyle behaviors and genetic predisposition. The absence of alcohol in 209 
disease development was stressed. Poor diet and excess weight were often viewed as causal, 210 
and the regional cultural identity as influential. Conversely, the diet-disease relationship and 211 
impact of excess weight was questioned by a few participants. 212 
 213 
“I understand that if I lose weight, it might improve it. I’m struggling to be convinced by that.” (F, 55 214 
years 05) 215 
 216 
NAFLD specific self-care priorities and acceptance for dietary self-control was imperceptible. 217 
Although, it was generally recognized that high-quality dietary patterns improve life expectancy 218 
and health outcomes. In some cases personal healthy dietary behaviors were shared to 219 
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emphasize that further dietary changes weren’t needed. Participants were less likely to engage in 220 
the change process if they interpreted their habitual diet as either low or high Mediterranean.  221 
 222 
“Well, I haven’t had to make many changes, so it’s not been a challenge. I’ve just been more 223 
aware.” (F, 55 Years 05).   224 
 225 
The process of dietary behavior change 226 
Readiness and psychological factors  227 
Placing high value on potential health benefits and the expectation of dietary enjoyment increased 228 
participants’ readiness to change their habitual diet.  Improved Mediterranean diet adoption was 229 
linked to responses portraying self-determination and high intrinsic motivation. Conversely, 230 
difficulties were related to perceived helplessness and increased demand for food skills.  231 
 232 
“Yes, I want to change; I’m finding it hard to change, but I want to change. I’m a creature of habit.” 233 
(F, 38 years) 234 
 235 
Higher internal locus of control–belief in one’s own ability to control events-assertiveness and a 236 
balanced relationship with food supported diet modifications. Stressful experiences, ambivalence 237 
and optimistic bias hindered the process. High responsiveness to cues outside of hunger, resulting 238 
in treats, cheats or rewards were obstacles to following dietary advice.  Attitudes diverged on 239 
whether it was feasible to consume Mediterranean diet across seasons.   240 
 241 
"When I left work this afternoon I walked into the administration office I saw the big bag of 242 
Maltesers® there made up of little bags. I know I shouldn’t, but I did.” (M, 59 years) 243 
 244 
“Then Christmas came in the middle of it, and Christmas just isn’t geared up for the Mediterranean 245 
diet, really, is it?” (F, 38 years) 246 
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Practical and social  247 
Mediterranean diet intervention was highly acceptable to many participants with impressions of 248 
food abundance, variety and enjoyment. The cost of Mediterranean diet ingredients did not 249 
emerge as an obstacle to participants following this dietary pattern.  Portion sizes were typically 250 
considered adequate and a range of individual Mediterranean foods were consumed. Enhanced 251 
nutrition knowledge/skills and self-regulation supported diet uptake.   252 
 253 
“I’m just amazed at how much fruit and vegetables you can buy for quite a low amount of money.” 254 
(M, 59 years) 255 
 256 
Participants encountered difficulties with an obesogenic environment and a societal pressure to 257 
consume. The unhealthy selections available in institutions, workplaces and supermarkets 258 
negatively impacted diet maintenance. Work patterns and dietary habits were problematic for 259 
appetite regulation and food routines.  In contrast, easy access to budget supermarkets, good 260 
transport links and having family diet supporters were regarded positively.  261 
 262 
“I always bring my food with me, which makes me look a bit like an outsider. So, I have to fight my 263 
corner.” (F, 55 years 05) 264 
 265 
Dietary management 266 
Personalized approaches combining nutrition education and counselling skills induced diet 267 
modifications. The dietitian was considered an advocate of flexible dietary restraint and the 268 
Mediterranean style of eating. The importance of role modelling and credibility was identified. 269 
Participants reported food selections based on therapeutic benefits with nutritional quality, 270 
freshness and palatability. However, taste preferences were a clear barrier in some cases and 271 
sustained dietary changes also appeared dependent upon improvements in clinical parameters.   272 
 273 
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79% of participants achieved weight reduction.  These individuals largely perceived the adoption 274 
of the diet as more feasible, conveying a greater magnitude of dietary changes.  275 
 276 
(F, 55 years 04) reduced her weight by 5.6kg and said "I would want them to know it’s really easy. 277 
It’s very enjoyable, and a variety of foods.”  “There is enough food you can eat.”  278 
 279 
Conversely, in those cases where weight loss was not attained, difficulties applying dietary 280 
changes were more often reported.  281 
 282 
(F, 38 years) gained 2.3kg and stated “What I found hard was, because I rely quite a lot on 283 
convenience, preparing everything from scratch, you weren’t able to just grab something and go 284 
you had to think about it.”  285 
 286 
Treatment adaptations 287 
Measures to shape future diet interventions were suggested, such as joint creation of resources 288 
and personalized dietary input on a quarterly basis.  Face-to-face contacts were preferred with 289 
support from an online program, thus enabling housebound patients and those from a wider 290 
geographical area to engage. Telephone contacts appeared to be least helpful and groups cost-291 
effective and motivating. Mediterranean diet promotion in clinical settings and increased coverage 292 
in books and television facilitated diet uptake. 293 
 294 
Discussion 295 
The Mediterranean diet is widely studied and has beneficial properties in a broad range of 296 
diseases (17, 18). The PREDIMED study reported that high Mediterranean diet adoption (MDPS 297 
≥9), was associated with significantly lower odds ratios for obesity prevalence and CVD risk. 298 
Furthermore, a 2-point increase in MDPS was associated with reduced risk of ill-health (19, 20).   299 
Our results are consistent with emergent evidence within the NAFLD population (21).  300 
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Mediterranean diet adoption significantly increased and was associated with modest but significant 301 
bodyweight reduction and increased HDL-cholesterol in participants. These findings suggest this 302 
dietary pattern alongside other lifestyle changes contribute to an improved CVD risk profile in 303 
NAFLD patients.  304 
 305 
Perhaps unsurprisingly, Mediterranean diet consumption was lower in the study population (MDPS 306 
7.6+2.5) than in a Mediterranean population (MDPS 8.7+2.0) (20).  Accordingly, Mediterranean 307 
diet interventions outside the Mediterranean region may face additional challenges and warrant 308 
specific approaches. Interestingly, we identified no association between socio-demographic 309 
characteristics at baseline or end-of study MDPS, though the ability to detect associations may 310 
have been impeded by small numbers.  311 
 312 
Barriers and facilitators of Mediterranean diet adoption and maintenance  313 
NAFLD conceptualization  314 
Acceptance of NAFLD as a disease and nutritional care engagement is impacted by patients 315 
understanding of their condition. Poor health service utilization may be in part attributed to lack of 316 
symptoms, and viewing long-term diseases and their outcomes as inevitable (22, 23). Therefore, 317 
clinicians should stress that NAFLD is treatable and even reversible if diet improvements are 318 
sustained (6).  Perceived stigma in obesity and liver disease poses psychological burden. In this 319 
study, the absence of alcohol in NAFLD causality, social desirability and optimistic bias was 320 
emphasized.   321 
 322 
Readiness and psychological factors  323 
Participants readiness to change, underpinned diet adoption and maintenance with low intrinsic 324 
motivation and ambivalence obstacles to following dietary advice. This is consistent with recent 325 
findings that willpower and willingness to change affect healthy eating adoption (24-26). Self-326 
efficacy is one of the best psychological predictors of good outcomes in lifestyle interventions that  327 
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target obese adults, but is low in NAFLD patients compared to other liver disease patients (27, 328 
28).  329 
 330 
Self-regulation and higher autonomous motivation have been found to be positive predictors of 331 
diet adherence in obesity interventions, which is in line with our findings (29).  The negative impact 332 
of treats or rewards, and life stressors were evident and appear common in interventions targeting 333 
obese adults (28). Thus, having a balanced relationship with food is pivotal to success as well as 334 
the ability to manage moods, emotions and stressors. 335 
 336 
Dietary management 337 
Tangible markers of weight loss, improved glycemic control and well-being expedited diet 338 
maintenance. Our data supports the view that individuals with weight loss found the adoption of 339 
the diet more straightforward, as evidenced by the diet modifications reported. Published data 340 
indicates early weight loss is a prominent predictor of treatment adherence among obese patients 341 
and subsequent weight loss (28, 30). Trust in the dietitian–patient relationship encompassing; 342 
professional credibility; role modelling; and diet advocacy induced changes. Participants want 343 
effective personalized interactions and not standardized approaches.  344 
 345 
Nutrition knowledge was significantly associated with Mediterranean diet adherence and lower 346 
obesity prevalence among the Molise population, Italy (MOLI-SANI study) (31).  Nutrition 347 
counselling interventions have also been shown to induce moderate diet improvements previously 348 
(32). Hence, nutrition education and counselling are crucial ingredients in diet interventions. 349 
Although, more intensive approaches may have greater effectiveness than brief interventions (24).  350 
 351 
Practical and social factors 352 
One of the most significant findings in our study is that the Mediterranean diet is an acceptable 353 
healthy eating model in a non-Mediterranean country (24, 33). There were impressions of cost 354 
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neutrality, despite the study population having a mean weekly household income that is £227.4, 355 
approx. €258.8 lower than the UK average (34).  Furthermore, previous research found diet 356 
changes did not equate to significantly increased purchase costs (1-point increase MDPS 357 
equivalent to £0.55) (24), which is supported by published cost analysis (35, 36).  358 
 359 
Commitment to a diet intervention amongst other obligations appears demanding. Diet saboteurs 360 
and spousal conflict impacted the home environment to undermine food routines. Consistent with 361 
our data, research that examined barriers to healthy eating adoption also identified time pressures, 362 
busy lifestyle, irregular working hours and desire for convenience (37).  363 
 364 
Treatment adaptations 365 
The various treatment adaptations suggested underscores the futility of a one-size-fits-all 366 
approach. The joint development of intervention tools between patients and clinicians may 367 
optimize treatment adoption and maintenance. Personalized dietary input on a quarterly basis 368 
combined with an online program was also favored. Earlier intervention studies have used these 369 
components effectively (38).  370 
 371 
The MOLI-SANI study reported that exposure to mass media information was significantly 372 
associated with greater adoption of a Mediterranean-style diet (41).  Furthermore, that participants 373 
found increased coverage in media, books, magazines and television induced dietary behavior 374 
change, which is consistent with our findings.   375 
 376 
The main limitation of the current study is potential for selection bias, with participants perhaps 377 
more health-motivated and interested in the diet intervention, which might not be applicable to the 378 
wider NAFLD population. However, steps were taken to address transferability by recruiting a 379 
purposive sample of individuals with diverse socio-demographics and making connections to the 380 
regional cultural and social context.   Further larger studies are needed to assess Mediterranean 381 
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diet uptake and its impact in a larger population. Another limitation was that a detailed assessment 382 
of Mediterranean diet impact on markers of liver function was not conducted. However, this study 383 
primarily focused on identifying barriers and facilitators to a Mediterranean diet in patients with 384 
NAFLD, rather than assessing its impact on the liver, which has already been subject to a 385 
controlled trial (9). The sample size may be considered small in an epidemiological context, but 386 
was sufficiently robust to achieve the aims of this mixed-methods study. 387 
 388 
Despite these limitations, this study adds to the body of literature indicating that a Mediterranean 389 
diet was highly acceptable, and its adoption was associated with positive clinical outcomes. The 390 
findings provide simple ways in which clinicians can optimize patient consultations in clinical 391 
practice. This study is the first to explore the factors that influence Mediterranean diet adoption in 392 
a northern European NAFLD patient population and demonstrates its potential to be translated in 393 
regions that consume a typical western diet. Importantly, no specific advice on calorie allowances 394 
or physical activities was given during the intervention and this still led to positive effects on 395 
bodyweight and HDL levels.  396 
 397 
A 12-week Mediterranean diet intervention was acceptable in NAFLD patients and was associated 398 
with positive changes in bodyweight and serum HDL levels. The Mediterranean diet intervention 399 
effectively modified diet adoption and maintenance in a northern European patient population. 400 
Furthermore, during dietary intervention we identified a range of perceived barriers and facilitators, 401 
which may enable a more targeted and personalized intervention approach. Treatment 402 
adaptations to enhance personalized nutritional care were highlighted alongside the benefits of 403 
sustained exposure to Mediterranean diet information in media and clinical sources.  404 
 405 
 406 
 407 
 408 
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Table 1. Baseline characteristics of Mediterranean diet population. Values are means (SD).  510 
Variable Mean (SD), n=19 
Gender (% Female) 63.2 
White British (%) 89.4 
Age (years) 58.5 (10.6) 
Married or cohabiting (%) 78.9 
Type II diabetes (%) 68.4 
Weight (kg) 99.2 (17.0) 
BMI (kg/m2) 36.2 (6.3) 
<30 5.3%  
30-34.9 47.4%  
35-39.9 26.3%  
>40 21%  
MDPS (<5, 6-9, >10) 7.6 (2.5) 
511 
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Figure legends 
Fig.1. Themes, subordinate-themes, barriers and facilitators 
Fig. 2. Mediterranean diet adoption at baseline and after 12-weeks diet intervention. 
Significance: p=.006 (paired t-test) 
Fig. 3. Bodyweight at baseline and after 12-weeks diet intervention. Significance: p=.001 
(paired t-test) 
 
 
 



